Maximus Inc (FRA:MMY)
€ 50 -4 (-7.41%) Market Cap: 2.69 Bil Enterprise Value: 4.14 Bil PE Ratio: 8.74 PB Ratio: 1.80 GF Score: 73/100

Q3 2026 Maximus Inc Earnings Call Transcript

Aug 6, 2026 / 01:00 PM GMT
Release Date Price: €54 (-0.92%)

Key Points

Positve
  • Maximus Inc (MMS) reported strong Q3 fiscal 2026 results with revenue of $1.28 billion, in line with expectations, and adjusted EPS of $2.22, up from $2.16 in the prior year.
  • Adjusted EBITDA margin improved to 15.0% in Q3, up from 14.7% year-over-year, driven by strong execution and efficiency-enhancing technology investments.
  • US Federal Services segment operating margin increased to 18.6% in Q3, up from 18.1% in the prior year, reflecting continued efficiency gains.
  • US Services segment is expected to return to positive mid single-digit organic growth in Q4, driven by Medicaid population activities and legislative-driven program changes.
  • The company has a robust pipeline of $50.4 billion, with 57% new work, and a significant step-up in awarded but unsigned contracts ($1.35 billion), indicating future growth potential.
  • AI adoption is accelerating, with 75-80% of new bids containing AI requirements, and AI-driven improvements have led to a 3.5% operating margin improvement in five contracts.
  • Defense and national security business is gaining traction with notable wins at the Air Force and TSA, and a $47 billion addressable market identified.
  • Cash collections from a major federal customer accelerated in July, with $245 million received since June 30, supporting the expectation of DSO falling below 70 days by year-end.
  • The company repurchased $50 million in shares during Q3 and has $400 million remaining under its buyback authorization, demonstrating commitment to shareholder returns.
Negative
  • A customer-directed pause in performance incentives on the VA Medical Disability Exam (VAMDE) program is expected to reduce Q4 fiscal 2026 diluted EPS by approximately $0.35, leading to a revised EPS guidance range of $7.90-$8.20.
  • The VAMDE incentive pause is expected to continue through December 31, 2026, impacting Q1 fiscal 2027 earnings, with uncertainty about the successor contract structure.
  • US Federal Services revenue declined year-over-year in Q3, partly due to reduced natural disaster support and temporary clinical volume surges.
  • Outside the US segment revenue declined year-over-year due to volume variances across clinical and employment services programs, with only a break-even operating profit expected for the full year.
  • Cash flow from operations was negative $125 million in Q3, with free cash flow outflow of $137 million, due to elevated DSO of 98 days from administrative delays at a major federal customer.
  • The total pipeline value decreased compared to the prior quarter due to procurement delays, revisions, and cancellations in the federal civilian market, leading to slower opportunity maturation.
  • Year-to-date signed contract awards of $1.25 billion translate to a book-to-bill ratio of only 0.5 times, indicating a slower pace of new contract signings.
  • Medicaid work requirements implementation is progressing slower than expected, with states facing complexity from the CMS interim final rule, potentially delaying revenue contributions.
  • The company faces uncertainty in the federal procurement environment, with agencies awarding more bridge contracts and short-term extensions, making timing of awards difficult to predict.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MMS.N - Maximus, Inc.
Q3 2026 Maximus Inc Earnings Call
Aug 06, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the Maximus fiscal 2026 3 quarter earnings conferences and only a question-and-answer session will follow the formal presentation.

If anyone should require operator assistance, please press 0 on your telephone keypad.

As a reminder, this conference is being recorded.

It is now my pleasure to introduce James Francis, Vice President of Investor Relations.

Please go ahead.

Good morning and thanks for joining us.

With me today is Bruce Caswell, President and CEO, and David Mutrin, CFO.

I'd like to remind everyone that a number of statements being made today will be forward-looking in nature, please remember that such statements are only predictions.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot